Baxter, a global leader in Dialysis Care, reaffirms its commitment to equitable access to care on World Kidney Day
MANILA, Philippines, March 11, 2021 /PRNewswire/ -- Baxter, a global leader in dialysis care, is proud to support this year's World Kidney Day, under the theme "Living Well with Kidney Disease".
Kidney disease affects approximately 10% of the global population, and 2% of the general population in the Philippines. Sadly, the incidence of patients with end-stage renal disease (ESRD) requiring dialysis has grown rapidly in recent years, as a result of an increasingly ageing population, as well as a higher prevalence of diabetes and high blood pressure.
Most ESRD patients will require lifelong dialysis treatment either through Hemodialysis (HD), administered in a specialised clinic several times a week, or Peritoneal Dialysis (PD), a home therapy which allows the patient to have treatment in the comfort of their surroundings. Our vision at Baxter is to transform renal care and give patients flexibility when it comes to treatment and care of their chronic condition. As well as providing care for patients receiving treatment in Dialysis clinics across the country, Baxter also supports Peritoneal Dialysis, commonly referred to as PD, which is conducted in the home.
Last month, a state-of-the-art NKTI-Baxter PD Center of Excellence facility for PD patients was inaugurated in the heart of Metro Manilla, the culmination of Baxter's two-year collaboration with the National Kidney and Transplant Institute (NKTI), one of the first Public-Private Partnerships of this kind in the Philippines. The pandemic brought into sharp focus the need to help patients gain access to home dialysis, where they can socially distance during this unprecedented global health crisis. COVID-19 poses a particular risk to vulnerable dialysis patients, who typically suffer from comorbidities and immune dysfunction associated with kidney failure. Baxter believes this treatment modality empowers patients to manage their own care, with minimal disruption to their daily lives, whilst alleviating the current pressure the Philippine's healthcare system.
Dhananjay Rajore, Commercial Director, Baxter Philippines said "We are proud to once again join the World Kidney Day organization in honor of our patients with kidney disease, their families and healthcare providers. World Kidney Day is a global time of awareness about the importance of effective kidney disease symptom management and empowerment for the millions of patients on dialysis across the country.
We believe kidney care is a journey that should begin with symptom management (chronic kidney disease management), before dialysis is required. If dialysis is required along the journey, eligible patients should have access to home therapy to support their quality of life, and to help them maintain social distance during the COVID-19 pandemic. In addition to being at higher risk for contracting viruses, a recent study of dialysis patients who contracted COVID-19 indicated they experienced a nearly 25% mortality rate, much higher than those who do not get the virus. We join World Kidney Day in calling upon everyone to advocate for patients' access to education, technology and procedures that help them live well with kidney disease".
Every day, millions of patients and caregivers rely on Baxter's leading portfolio of critical care, nutrition, renal, hospital and surgical products. For more than 85 years, we've been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen. With products, technologies and therapies available in more than 100 countries, Baxter's employees worldwide are now building upon the company's rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations.
To learn more, visit www.baxter.com and follow us on Twitter, LinkedIn and Facebook.
Upcoming Life Sciences Events
- May 2021
- Shanghai: ChinaBio® Partnering Forum
- European Health-tech Innovation Week
- 7th Annual Immuno-Oncology Innovation Forum